Why did Healthcare Services Group (HCSG) stock move recently?

On 7/23/2026, Healthcare Services Group moved -4.8% — HCSG fell ~5% after reporting Q2 2026 results that beat EPS estimates ($0.32 vs $0.22) but missed revenue slightly ($470.8M vs $471.2M expected) with only 2.7% YoY growth; investors appeared focused on decelerating top-line despite reaffirmed mid-single-digit 2026 outlook and Q3 guidance of $475-485M. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Healthcare Services Group (HCSG) overvalued or fairly valued?

MarketChacha shows Healthcare Services Group's valuation in context — a trailing P/E of about 25.7, a forward P/E of about 17.5, a price-to-book of about 2.8 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Healthcare Services Group's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.60×) from reported figures — education, not a rating.

What is Healthcare Services Group's revenue?

Healthcare Services Group reported revenue of $1.8B for FY2025, with net profit of $59.1M, per official filings.

What is the share price of Healthcare Services Group (HCSG)?

Healthcare Services Group last traded at $21.59 (+2.4% on the day), as of 8/17/2026 — a delayed quote shown for education, not investment advice.

Healthcare Services Group

HCSG · NYSE · Industrials · United States

Snapshot

TickerHCSG

ExchangeNYSE

SectorIndustrials

IndustryMedical Care Facilities

CountryUnited States

Employees36,000

HeadquartersBensalem, United States

Websitewww.hcsgcorp.com

Filings tracked11

About Healthcare Services Group

Healthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. The company operates in two segments, Environmental Services and Dietary. Its Environmental Services segment engages in cleaning, disinfecting, and sanitizing of resident rooms and common areas of the customers' facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing, and other assorted linen items utilized at the customers' facilities. The Dietary segment is involved in the management of the customers' dietary departments, which focus on food purchasing, meal preparation, and professional dietitian services, such as the development of menus that meet the dietary needs of residents; and the provision of on-site management and clinical consulting services. It serves long-term and post-acute care facilities, hospitals, and the healthcare industry through referrals and solicitation of target facilities. The company was incorporated in 1976 and is headquartered in Bensalem, Pennsylvania.

Who owns it

Insiders1.4%
Institutions98.6%
Public & other0.0%

383 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.16.57%
Vanguard Portfolio Management LLC7.40%
Vanguard Capital Management LLC4.43%
State Street Corporation4.25%
American Century Companies Inc3.88%
Geode Capital Management, LLC3.73%
Dimensional Fund Advisors LP3.62%
FMR, LLC3.35%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.60×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend2.3% → 3.2%

Margin has held broadly steady over the period — stable profitability.

Growth qualityrev 5% · PAT 24%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $502.0M · EPS 0.26

Est. earnings growth -41.6%

Next fiscal year

Rev $2.0B · EPS 1.23

Est. earnings growth +2.2%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$1.8B

Net margin

3.2%

ROE

11.6%

Revenue CAGR (2y)

+4.8%

Profit CAGR (2y)

+24.0%

EPS (FY2025)

0.81

Net profit (FY2025)

$59.1M

Ask MarketChacha about HCSG

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Jul 23, 2026
HCSG fell ~5% after reporting Q2 2026 results that beat EPS estimates ($0.32 vs $0.22) but missed revenue slightly ($470.8M vs $471.2M expected) with only 2.7% YoY growth; investors appeared focused on decelerating top-line despite reaffirmed mid-single-digit 2026 outlook and Q3 guidance of $475-485M.
source 1 ↗source 2 ↗source 3 ↗· confidence: medium
Jul 22, 2026
HCSG fell despite beating Q2 EPS and revenue estimates because it reaffirmed its unchanged mid-single-digit 2026 revenue growth outlook and provided Q3 revenue guidance of $475M-$485M that was viewed as insufficiently bullish.
source 1 ↗source 2 ↗source 3 ↗· confidence: medium

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$1.8B	$59.1M	0.81	3.2%	11.6%
FY2024	$1.7B	$39.5M	0.53	2.3%	7.9%
FY2023	$1.7B	$38.4M	0.52	2.3%	8.4%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$470.8M	$22.7M	0.32	4.8%
2026Q1	$462.8M	$26.1M	0.37	5.6%
2025Q3	$464.3M	$43.0M	0.59	9.3%
2025Q2	$458.5M	$-32.4M	-0.44	-7.1%
2025Q1	$447.7M	$17.2M	0.23	3.8%
2024Q3	$428.1M	$14.0M	0.19	3.3%
2024Q2	$426.3M	$-1.8M	-0.02	-0.4%
2024Q1	$423.4M	$15.3M	0.21	3.6%
2023Q3	$411.4M	$-5.0M	-0.07	-1.2%
2023Q2	$418.9M	$8.3M	0.11	2.0%
2023Q1	$417.2M	$11.7M	0.16	2.8%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC7/24/2026
8-K — Results of operations, Exhibits
SEC7/22/2026material
8-K — Shareholder vote results, Exhibits
SEC5/27/2026material
10-Q filing
SEC4/24/2026
8-K — Results of operations, Exhibits
SEC4/22/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC4/13/2026material
10-K filing
SEC2/13/2026
8-K — Results of operations, Exhibits
SEC2/11/2026material

2025

10-Q filing
SEC10/24/2025
8-K — Results of operations, Exhibits
SEC10/22/2025material
10-Q filing
SEC7/25/2025

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.